Market revenue in 2023 | USD 6,774.1 million |
Market revenue in 2030 | USD 10,970.3 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Nasal sprays |
Fastest growing segment | Nasal Drops |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nasal Sprays, Nasal Drops, Nasal Gels, Nasal Powders |
Key market players worldwide | AstraZeneca PLC, Pfizer Inc, OptiNose Inc, Becton Dickinson & Co, Dr Reddy's Laboratories Ltd ADR, GlaxoSmithKline, B.F. Ascher & Company, Pendopharm, Douglas Pharmaceuticals, ENT Technologies, Naveh Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nasal drug delivery technology market will help companies and investors design strategic landscapes.
Nasal sprays was the largest segment with a revenue share of 39.19% in 2023. Horizon Databook has segmented the Latin America nasal drug delivery technology market based on nasal sprays, nasal drops, nasal gels, nasal powders covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America nasal drug delivery technology market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America nasal drug delivery technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account